Metastases of Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients. The "SCOPE-ITSCC Metastases Study"
NCT ID: NCT01976468
Last Updated: 2019-07-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2013-11-30
2025-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cutaneous Squamous Cell Carcinoma Staging Study
NCT05695222
Immunotherapy +/- EGFR Inhibitor In Advanced/Metastatic cSCC: Tackling Primary And Secondary Resistance
NCT03666325
Patient Reported Outcome Measures After Treatment of Skin Cancers on the Face
NCT04485442
Outcome Research of a European Registry Platform on Real-world Treatment Data of Patients with Advanced NMSC
NCT05741073
Usefulness of Post-Operative Radiotherapy in High-grade Cutaneous Squamous Cell Carcinoma: an Observational Study
NCT06879964
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SCC metastasis
organ transplant recipients
SCC metastasis
occurrence of SCC metastasis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SCC metastasis
occurrence of SCC metastasis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Histologically proven cutaneous invasive SCC at time of inclusion
Exclusion Criteria
* History of metastases of cutaneous SCC
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Leiden University Medical Center
OTHER
University of Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Günther Hofbauer, Prof MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital Zurich, Division of Dermatology
Jan Nico Bouwes Bavinck
Role: STUDY_CHAIR
Leiden University Medical Center
Roel Genders, MD
Role: STUDY_DIRECTOR
Leiden University Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Leiden University Medical Center
Leiden, , Netherlands
University Hospital Zurich, Division of Dermatology
Zurich, Canton of Zurich, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SCOPE-ITSCC metastases
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.